Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy

Hyperammonemia has been reported to be associated with patients who receive valproic acid (VPA) therapy. This study aimed to determine the risk factors for hyperammonemia in patients with epilepsy treated with VPA. One hundred and fifty-eight adult patients with epilepsy aged older than 17 years who...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Yu-Lung, Huang, Chi-Ren, Lin, Chih-Hsiang, Lu, Yan-Ting, Lu, Cheng-Hsien, Chen, Nai-Ching, Chang, Chiung-Chih, Chang, Wen-Neng, Chuang, Yao-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616274/
https://www.ncbi.nlm.nih.gov/pubmed/25192484
http://dx.doi.org/10.1097/MD.0000000000000066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616274/
https://www.ncbi.nlm.nih.gov/pubmed/25192484
http://dx.doi.org/10.1097/MD.0000000000000066

Ejemplares similares